Jiangsu Apon Medical Technology Co., Ltd.
Symboli: 300753.SZ
SHZ
12.98
CNYMarkkinahinta tänään
-103.9099
P/E-suhde
0.0000
PEG-suhde
1.64B
MRK Cap
- 0.00%
DIV Tuotto
Jiangsu Apon Medical Technology Co., Ltd. (300753-SZ) Tilinpäätöstiedotteet
Tase
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 249.3 | 274.7 | 388.6 | |||||||||
balance-sheet.row.short-term-investments | 0 | -22.7 | -7.6 | -1.5 | |||||||||
balance-sheet.row.net-receivables | 0 | 133.6 | 139.2 | 102.3 | |||||||||
balance-sheet.row.inventory | 0 | 61 | 67.4 | 31.7 | |||||||||
balance-sheet.row.other-current-assets | 0 | 1.5 | 2.9 | 0.7 | |||||||||
balance-sheet.row.total-current-assets | 0 | 445.4 | 484.2 | 523.3 | |||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 207 | 212.8 | 168.6 | |||||||||
balance-sheet.row.goodwill | 0 | 53.2 | 69.4 | 33.9 | |||||||||
balance-sheet.row.intangible-assets | 0 | 35.6 | 33.2 | 37.7 | |||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 88.8 | 102.6 | 71.6 | |||||||||
balance-sheet.row.long-term-investments | 0 | 103.8 | 87 | 60.5 | |||||||||
balance-sheet.row.tax-assets | 0 | 24.4 | 8.7 | 2.1 | |||||||||
balance-sheet.row.other-non-current-assets | 0 | 0.8 | 3.7 | 1.2 | |||||||||
balance-sheet.row.total-non-current-assets | 0 | 424.8 | 414.9 | 303.9 | |||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.total-assets | 0 | 870.2 | 899.1 | 827.2 | |||||||||
balance-sheet.row.account-payables | 0 | 46.9 | 27.8 | 31.4 | |||||||||
balance-sheet.row.short-term-debt | 0 | 33.8 | 2 | -3.4 | |||||||||
balance-sheet.row.tax-payables | 0 | 6.6 | 8.5 | 14.5 | |||||||||
balance-sheet.row.long-term-debt-total | 0 | 34.5 | 39.9 | 3.7 | |||||||||
Deferred Revenue Non Current | 0 | 1.9 | 2 | 2 | |||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||
balance-sheet.row.other-current-liab | 0 | 1.6 | 42.3 | 53.8 | |||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 36.7 | 42 | 2.2 | |||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.capital-lease-obligations | 0 | 34.5 | 39.9 | 3.7 | |||||||||
balance-sheet.row.total-liab | 0 | 183.9 | 118.5 | 87.4 | |||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.common-stock | 0 | 126 | 126 | 105 | |||||||||
balance-sheet.row.retained-earnings | 0 | 188.1 | 264.5 | 247.1 | |||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 41.5 | 41.5 | 36.5 | |||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 329.9 | 347.6 | 350.9 | |||||||||
balance-sheet.row.total-stockholders-equity | 0 | 685.6 | 779.6 | 739.5 | |||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 870.2 | 899.1 | 827.2 | |||||||||
balance-sheet.row.minority-interest | 0 | 0.8 | 0.9 | 0.3 | |||||||||
balance-sheet.row.total-equity | 0 | 686.4 | 780.5 | 739.8 | |||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||||
Total Investments | 0 | 81.1 | 79.4 | 59 | |||||||||
balance-sheet.row.total-debt | 0 | 68.4 | 39.9 | 3.7 | |||||||||
balance-sheet.row.net-debt | 0 | -180.9 | -234.8 | -384.8 |
Kassavirtalaskelma
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | -76.5 | 53.3 | 96.9 | |||||||||
cash-flows.row.depreciation-and-amortization | 0 | 19.6 | 15.4 | 9.7 | |||||||||
cash-flows.row.deferred-income-tax | 0 | -15.5 | -6.6 | 0.7 | |||||||||
cash-flows.row.stock-based-compensation | 0 | 15.5 | 6.6 | -0.7 | |||||||||
cash-flows.row.change-in-working-capital | 0 | 28.3 | -76.7 | -25.8 | |||||||||
cash-flows.row.account-receivables | 0 | 9.1 | -47.6 | -34 | |||||||||
cash-flows.row.inventory | 0 | 6.3 | -33.6 | -3.3 | |||||||||
cash-flows.row.account-payables | 0 | 28.4 | 11.1 | 10.7 | |||||||||
cash-flows.row.other-working-capital | 0 | -15.5 | -6.6 | 0.7 | |||||||||
cash-flows.row.other-non-cash-items | 0 | 4.1 | 26.3 | 2.6 | |||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -24.2 | -39.6 | -35.6 | |||||||||
cash-flows.row.acquisitions-net | 0 | 0.1 | -37.3 | 2.7 | |||||||||
cash-flows.row.purchases-of-investments | 0 | -3 | -22.5 | -52.4 | |||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 259 | 0.1 | 0.8 | |||||||||
cash-flows.row.other-investing-activites | 0 | -256.7 | 2.5 | 1.5 | |||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -24.8 | -96.7 | -83.1 | |||||||||
cash-flows.row.debt-repayment | 0 | -29.4 | 0 | -0.4 | |||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | |||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | |||||||||
cash-flows.row.dividends-paid | 0 | -0.6 | -31.5 | -32.3 | |||||||||
cash-flows.row.other-financing-activites | 0 | 54 | -4.3 | 0.4 | |||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 23.9 | -35.8 | -32.3 | |||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0 | 0 | |||||||||
cash-flows.row.net-change-in-cash | 0 | -25.5 | -114.3 | -32 | |||||||||
cash-flows.row.cash-at-end-of-period | 0 | 248.8 | 274.3 | 388.6 | |||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 274.3 | 388.6 | 420.6 | |||||||||
cash-flows.row.operating-cash-flow | 0 | -24.6 | 18.3 | 83.3 | |||||||||
cash-flows.row.capital-expenditure | 0 | -24.2 | -39.6 | -35.6 | |||||||||
cash-flows.row.free-cash-flow | 0 | -48.8 | -21.3 | 47.7 |
Tuloslaskelmarivi
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 323.8 | 461.2 | 443.1 | |||||||||
income-statement-row.row.cost-of-revenue | 0 | 163.8 | 166.3 | 188.6 | |||||||||
income-statement-row.row.gross-profit | 0 | 160 | 294.9 | 254.5 | |||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||
income-statement-row.row.other-expenses | 0 | -2.4 | -0.5 | -1.6 | |||||||||
income-statement-row.row.operating-expenses | 0 | 232 | 235.5 | 146.3 | |||||||||
income-statement-row.row.cost-and-expenses | 0 | 395.7 | 401.8 | 334.9 | |||||||||
income-statement-row.row.interest-income | 0 | 2.1 | 3.6 | 7.2 | |||||||||
income-statement-row.row.interest-expense | 0 | 2.5 | 1.1 | 0 | |||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -2.4 | -0.5 | -1.6 | |||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||
income-statement-row.row.other-operating-expenses | 0 | -2.4 | -0.5 | -1.6 | |||||||||
income-statement-row.row.total-operating-expenses | 0 | -2.4 | -0.5 | -1.6 | |||||||||
income-statement-row.row.interest-expense | 0 | 2.5 | 1.1 | 0 | |||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 19.6 | 15.4 | 9.7 | |||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||||||
income-statement-row.row.operating-income | 0 | -88.3 | 55.8 | 113.5 | |||||||||
income-statement-row.row.income-before-tax | 0 | -90.7 | 55.3 | 111.9 | |||||||||
income-statement-row.row.income-tax-expense | 0 | -14.2 | 2 | 15 | |||||||||
income-statement-row.row.net-income | 0 | -76.4 | 54.1 | 97 |
Usein kysytty kysymys
Mikä on Jiangsu Apon Medical Technology Co., Ltd. (300753.SZ) taseen loppusumma?
Jiangsu Apon Medical Technology Co., Ltd. (300753.SZ) kokonaisvarat ovat 870213234.000.
Mikä on yrityksen vuotuinen liikevaihto?
Vuotuinen liikevaihto on N/A.
Mikä on yrityksen voittomarginaali?
Yrityksen voittomarginaali on 0.567.
Mikä on yrityksen vapaa kassavirta?
Vapaa kassavirta on -0.266.
Mikä on yrityksen nettovoittomarginaali?
Nettovoittomarginaali on -0.043.
Mikä on yrityksen kokonaistulot?
Kokonaisliikevaihto on -0.061.
Mikä on Jiangsu Apon Medical Technology Co., Ltd. (300753.SZ) nettovoitto (nettotulos)?
Nettovoitto (nettotulos) on -76377405.540.
Mikä on yrityksen kokonaisvelka?
Kokonaisvelka on 68373296.000.
Mikä on yrityksen toimintakulujen määrä?
Toimintakulut ovat 231973871.000.
Mikä on yrityksen kassan määrä?
Yrityksen kassavarat ovat 0.000.